Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Clinical trial NCT04298567 · COMPLETED

Trial details

NCT number: NCT04298567
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Prevention of Atherothrombotic Events Coronary Artery Disease (CAD)Symptomatic Peripheral Artery Disease (Symptomatic PAD)

Start date: 2022-02-25
Primary completion: 2024-03-28
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.